However, most of the methods predict an increase of the disorder probability in the mutation distal regions we observe for BRAF that the cancer driver mutation is at the periphery of the kinase binding site and in an ordered region, while the non-driver mutations mostly occur in the disordered regions. This evidence concerns the gene BRAF and cancer.